News
Resources
Blog
Sites
The important role of antivirals in the fight against COVID-19
By Richard Moscicki, M.D. | October 6, 2021
Throughout the COVID-19 pandemic, public health officials have focused their response into four main areas: 1) rapid and accurate testing: 2) contact tracing systems to monitor outbreaks; 3)...
Read More
Understanding Long COVID-19
By Richard Moscicki, M.D. | September 29, 2021
The Centers for Disease Control and Prevention (CDC) defines long COVID as health problems lasting four or more weeks after first getting infected with the novel coronavirus, impacting as many as ...
Read More
Biosimilar User Fee Act (III) Performance Goals Letter will help increase options for patients and promote competition
By Richard Moscicki, M.D. | September 28, 2021
Last week, the U.S. Food and Drug Administration (FDA) released the Performance Goals Letter for the Biosimilar User Fee Act (BsUFA) III.
Read More
Upcoming graduate student summit will showcase pathways to success within the biopharmaceutical industry
By Stephen J. Ubl | September 28, 2021
I am excited to join with Dr. Michael L. Lomax, President & CEO, UNCF; Dr. James Gillespie, President & Co-Founder, Center for Healthcare Innovation (CHI); and Dr. Chad Womack, Co-Founder and...
Read More
Meeting Tomorrow: Looking ahead to PDUFA VII
By Andrew Powaleny | September 27, 2021
Tomorrow, PhRMA will participate at the U.S. Food and Drug Administration’s (FDA) public meeting on the reauthorization of the Prescription Drug User Fee Act (PDUFA VII).
Read More
Guest Series: PhRMA talks racial and health equity with Lauren Powell, VP US Health Equity and Community Wellness, Takeda
By Courtney Christian | September 27, 2021
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
Read More
Industry leaders discuss the impact of the drug pricing debate
By Brian Newell | September 23, 2021
This month, PhRMA hosted a media briefing with leaders within the biopharmaceutical industry to discuss the dangers of current proposals on government price setting, while also sharing alternative...
Read More
A global focus on ending the COVID-19 pandemic
By Stephen J. Ubl | September 22, 2021
Today, President Biden convened global leaders to confront the challenges around ending this pandemic. We stand with the president, all governments, organizations and sectors in a shared...
Read More
Five reasons tying VA prices to Medicare Part D misses the mark
By Nicole Longo | September 22, 2021
Some members of Congress are considering a government “negotiation” plan that would tie medicine prices in Medicare to those in the U.S. Department of Veterans Affairs (VA). This misguided...
Read More
PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics
By Jackie McRae | September 21, 2021
The COVID-19 pandemic has widened health disparities, including the gap in average life expectancy and outcomes for many chronic diseases. These inequities in health status and outcomes among...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
